AAV-GBA1

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS RELATED TO GLUCOSYLCERAMIDASE BETA 1 DEFICIENCY
US 20260216372 A1申请人: VOYAGER THERAPEUTICS INC优先权: 2023
CN
EP
US
WO
4 件公开
COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISORDERS RELATED TO GLUCOSYLCERAMIDASE BETA 1 DEFICIENCY
- EP 4705485 A1
  申请人: VOYAGER THERAPEUTICS INC优先权: 2023
  CN
  EP
  WO
  3 件公开
- WO 2025038805 A1
  申请人: VOYAGER THERAPEUTICS INC优先权: 2023
  WO
- WO 2025122530 A1
  申请人: VOYAGER THERAPEUTICS INC优先权: 2023
  WO
AAV-BASED MODULATION OF GBA1 AND RELATED COMPOSITIONS AND USES THEREOF
US 20250082686 A1申请人: ASPEN NEUROSCIENCE INC优先权: 2022
US
METHODS AND SYSTEMS DIRECTED TO THERAPEUTIC DELIVERY OF THE HUMAN GBA1 GENE
WO 2025137290 A1申请人: BROAD INST INC优先权: 2023
WO
AAV CAPSID MODIFICATIONS THAT ENABLE IMPROVED CNS-WIDE GENE DELIVERY THROUGH INTERACTIONS WITH THE TRANSFERRIN RECEPTOR
WO 2025155923 A1申请人: BROAD INST INC优先权: 2024
WO
ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TREATING PARKINSON'S DISEASE (PD)
WO 2025213066 A1申请人: CAPSIDA BIOTHERAPEUTICS INC优先权: 2024
WO